Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy
M Reig, Z Mariño, C Perelló, M Iñarrairaegui… - Journal of …, 2016 - Elsevier
Background & Aims The success of direct-acting antivirals (DAA) against hepatitis C is a
major breakthrough in hepatology. Until now, however, there are very few data on the effect …
major breakthrough in hepatology. Until now, however, there are very few data on the effect …
Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy.
M Reig, Z Mariño, C Perelló, M Iñarrairaegui… - Journal of …, 2016 - europepmc.org
Methods The study included patients with HCV infection and prior history of treated
hepatocellular carcinoma who achieved complete response and lacked'non-characterized …
hepatocellular carcinoma who achieved complete response and lacked'non-characterized …
[引用][C] Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy
M Reig, Z Mariño, C Perelló, M Iñarrairaegui… - Journal of …, 2016 - cir.nii.ac.jp
Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing
interferon-free therapy | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …
interferon-free therapy | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …
Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy
M Reig, Z Mariño, C Perelló… - Journal of …, 2016 - pubmed.ncbi.nlm.nih.gov
Background & aims The success of direct-acting antivirals (DAA) against hepatitis C is a
major breakthrough in hepatology. Until now, however, there are very few data on the effect …
major breakthrough in hepatology. Until now, however, there are very few data on the effect …
[PDF][PDF] Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy q
M Reig, Z Mariño, C Perelló, M Iñarrairaegui, A Ribeiro… - 2016 - darmzentrum-bern.ch
Background & Aims: The success of direct-acting antivirals (DAA) against hepatitis C is a
major breakthrough in hepatology. Until now, however, there are very few data on the effect …
major breakthrough in hepatology. Until now, however, there are very few data on the effect …
[PDF][PDF] Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy q
M Reig, Z Mariño, C Perelló, M Iñarrairaegui, A Ribeiro… - 2016 - natap.org
Background & Aims: The success of direct-acting antivirals (DAA) against hepatitis C is a
major breakthrough in hepatology. Until now, however, there are very few data on the effect …
major breakthrough in hepatology. Until now, however, there are very few data on the effect …
Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy.
M Reig, Z Mariño, C Perelló, M Iñarrairaegui, A Ribeiro… - 2016 - cabidigitallibrary.org
Abstract Background & Aims: The success of direct-acting antivirals (DAA) against hepatitis
C is a major breakthrough in hepatology. Until now, however, there are very few data on the …
C is a major breakthrough in hepatology. Until now, however, there are very few data on the …
[PDF][PDF] Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy q
M Reig, Z Mariño, C Perelló, M Iñarrairaegui, A Ribeiro… - 2016 - natap.org
Background & Aims: The success of direct-acting antivirals (DAA) against hepatitis C is a
major breakthrough in hepatology. Until now, however, there are very few data on the effect …
major breakthrough in hepatology. Until now, however, there are very few data on the effect …
Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy
M Reig, Z Mariño, C Perelló, M Iñarrairaegui… - Journal of …, 2016 - infona.pl
The success of direct-acting antivirals (DAA) against hepatitis C is a major breakthrough in
hepatology. Until now, however, there are very few data on the effect of hepatitis C virus …
hepatology. Until now, however, there are very few data on the effect of hepatitis C virus …
Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy
M Reig, Z Mariño, C Perelló… - Journal of …, 2016 - journal-of-hepatology.eu
Background & Aims The success of direct-acting antivirals (DAA) against hepatitis C is a
major breakthrough in hepatology. Until now, however, there are very few data on the effect …
major breakthrough in hepatology. Until now, however, there are very few data on the effect …